NCT01980667 - Study of Lurbinectedin (PM01183) in Combination With Cisplatin in Patients With Solid Tumors | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 30, 2014

Primary Completion Date

January 5, 2017

Study Completion Date

January 5, 2017

Conditions

Advanced Solid Tumors

Interventions

DRUG

lurbinectedin (PM01183)

lurbinectedin (PM01183) is presented as powder for concentrate for solution for infusion with two strengths, 1-mg and 4-mg vials.

DRUG

Cisplatin

vials containing 1 mg/ml concentrate for solution for infusion

Trial Locations (3)

Bellinzona

London

Newcastle